Literature DB >> 8307200

Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats.

M Llovera1, C García-Martínez, N Agell, M Marzábal, F J López-Soriano, J M Argilés.   

Abstract

Rats bearing the fast-growing AH-130 Yoshida ascites hepatoma showed a marked cachectic response which has been previously reported [Tessitore et al. (1987) Biochem. J. 241, 153-159]. Thus tumour-bearing animals showed significant decreases in body and muscle weight (soleus and gastrocnemius) as compared to both pair-fed and ad libitum-fed animals. These decreases were related to an enhanced proteolytic rate in the muscles of the tumour-bearing animals as measured by the tyrosine released in in vitro assays. In an attempt to elucidate which proteolytic system is directly responsible for the decrease in muscle mass, we have studied both lysosomal and non-lysosomal (ATP-dependent) proteolytic systems in this animal model. While the enzymatic activities of the main cathepsin (B and B + L) systems were actually decreased in gastrocnemius muscles of tumour-bearing rats, thus indicating that lysosomal proteolysis was not involved, the ubiquitin pools (both free and conjugated) were markedly altered as a result of tumour burden. These were associated with an increased ubiquitin gene expression in muscle of tumour-bearing rats, over 500% in relation to non-tumour bearers, thus suggesting that the ATP-dependent proteolytic system may be responsible for the muscle proteolysis and wastage observed in this animal tumour model. The fact that we have previously shown that TNF enhances the ubiquitinization of muscle proteins [García-Martínez et al. (1993) FEBS Lett. 323, 211-214], together with the high circulating levels of TNF detected in rats bearing the Yoshida hepatoma allows us to suggest that the cytokine may be responsible, most probably indirectly, for the activation of the referred proteolytic system in tumour-bearing rats.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8307200     DOI: 10.1016/0014-5793(94)80290-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  25 in total

Review 1.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

2.  Death receptor-associated pro-apoptotic signaling in aged skeletal muscle.

Authors:  Emidio E Pistilli; Janna R Jackson; Stephen E Alway
Journal:  Apoptosis       Date:  2006-12       Impact factor: 4.677

Review 3.  The 20S/26S proteasomal pathway of protein degradation in muscle tissue.

Authors:  B Dahlmann; L Kuehn
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

4.  Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients.

Authors:  O Mansoor; B Beaufrere; Y Boirie; C Ralliere; D Taillandier; E Aurousseau; P Schoeffler; M Arnal; D Attaix
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

Review 5.  Adaptation of the ubiquitin-proteasome proteolytic pathway in cancer cachexia.

Authors:  D Attaix; L Combaret; T Tilignac; D Taillandier
Journal:  Mol Biol Rep       Date:  1999-04       Impact factor: 2.316

Review 6.  The ubiquitin-proteasome pathway: review of a novel intracellular mechanism of muscle protein breakdown during sepsis and other catabolic conditions.

Authors:  P O Hasselgren; J E Fischer
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

7.  Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats.

Authors:  S H Lecker; V Solomon; S R Price; Y T Kwon; W E Mitch; A L Goldberg
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

8.  Coordinate activation of lysosomal, Ca 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle.

Authors:  D Taillandier; E Aurousseau; D Meynial-Denis; D Bechet; M Ferrara; P Cottin; A Ducastaing; X Bigard; C Y Guezennec; H P Schmid
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  Formoterol treatment downregulates the myostatin system in skeletal muscle of cachectic tumour-bearing rats.

Authors:  Sílvia Busquets; Míriam Toledo; Enrica Marmonti; Marcel Orpí; Eva Capdevila; Angelica Betancourt; Francisco J López-Soriano; Josep M Argilés
Journal:  Oncol Lett       Date:  2011-10-13       Impact factor: 2.967

Review 10.  Biomedical consequences of alcohol use disorders in the HIV-infected host.

Authors:  Patricia E Molina; Gregory J Bagby; Steve Nelson
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.